EnBio Holdings (TSE:6092) Total Operating Expense: 円2,069 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6092 EnBio Holdings Inc TSE:6092
58 GF Score
Price 円708.00
GF Value 円799.37
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is EnBio Holdings Total Operating Expense?

EnBio Holdings TSE:6092 -2.75% 58 Total Operating Expense is 円2,069 Mil as of Mar. 2026. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円799.37 (Modestly Undervalued). The stock has 4 warning signs investors should review.

EnBio Holdings's Total Operating Expense for the three months ended in Mar. 2026 was 円561 Mil. EnBio Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,069 Mil.

EnBio Holdings Total Operating Expense Related Terms

EnBio Holdings Total Operating Expense Historical Data

* Premium members only.

The historical data trend for EnBio Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EnBio Holdings Total Operating Expense Chart

EnBio Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,196.93 1,407.07 1,668.88 1,814.00 2,069.00

EnBio Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 502.00 504.00 502.00 561.00
TSE:6092
58GF Score
EnBio Holdings Inc TSE:6092
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EnBio Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,069 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of 円2,069 Mil mean?
EnBio Holdings (TSE:6092) has a Total Operating Expense of 円2,069 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on EnBio Holdings and its competitors.
Is EnBio Holdings' Total Operating Expense too high?
EnBio Holdings' current Total Operating Expense is 円2,069 Mil. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Total Operating Expense compare to CTAS and CPRT?
EnBio Holdings' Total Operating Expense of 円2,069 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Business Services company?
A good Total Operating Expense depends on the Business Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on EnBio Holdings and its competitors. EnBio Holdings's current Total Operating Expense is 円2,069 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Modestly Undervalued. The stock's GF Value™ is 円799.37, compared to a current price of 円708.00 — trading 11.4% below its estimated fair value. The current Total Operating Expense is 円2,069 Mil. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Total Operating Expense is 円2,069 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EnBio Holdings (TSE:6092) Overvalued in 2026?

Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued. The current stock price of 円708.00 is trading 11.4% below its estimated GF Value™ of 円799.37. GuruFocus considers EnBio Holdings to be Modestly Undervalued.

Key valuation signals for TSE:6092:

  • Total Operating Expense: 円2,069 Mil
  • GF Value™: 円799.37 vs. price of 円708.00 (11.4% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EnBio Holdings Business Description

Address Tokyo Kandata cho 2-11 O-machi Takaku Building 3F, Chiyoda-ku, Tokyo, JPN
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score

Get the complete analysis for TSE:6092

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円708.00
Price
円799.37
GF Value